Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
2001.
Current Awareness.
Pharmacoepidemiology and Drug Safety,
Vol. 10,
Issue. 7,
p.
693.
Ipekçi, S.
and
Birsöz, S.
2001.
Discinesia tardía causada por el antipsicótico atípico risperidona y curada por el uso de olanzapina, otro fármaco de la misma clase.
European psychiatry (Ed. Española),
Vol. 8,
Issue. 8,
p.
540.
&NA;
2001.
Risperidone: Tardive dyskinesia resolved with olanzapine: case report.
Reactions Weekly,
Vol. &NA;,
Issue. 869,
p.
11.
Humbert, T
2002.
Dyskinésies tardives pithiatiques chez un jeune schizophrène séropositif au VIH traité.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 160,
Issue. 9,
p.
666.
Turrone, Peter
Remington, Gary
and
Nobrega, José N.
2002.
The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy?.
Neuroscience & Biobehavioral Reviews,
Vol. 26,
Issue. 3,
p.
361.
Fernandez, Hubert H.
and
Friedman, Joseph H.
2003.
CLASSIFICATION AND TREATMENT OF TARDIVE SYNDROMES.
The Neurologist,
Vol. 9,
Issue. 1,
p.
16.
Carvalho, R.C
Silva, R.H
Abı́lio, V.C
Barbosa, P.N
and
Frussa-Filho, R
2003.
Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice.
Brain Research Bulletin,
Vol. 60,
Issue. 1-2,
p.
115.
Ellard, John
2004.
Movement Disorders and the Treatment of Schizophrenia.
Australasian Psychiatry,
Vol. 12,
Issue. 4,
p.
409.
Ellard, John
2004.
Movement Disorders and the Treatment of Schizophrenia.
Australasian Psychiatry,
Vol. 12,
Issue. 4,
p.
409.
Trosch, Richard M.
2004.
Neuroleptic‐Induced Movement Disorders: Deconstructing Extrapyramidal Symptoms.
Journal of the American Geriatrics Society,
Vol. 52,
Issue. s12,
Karama, Sherif
and
Lal, Samarthji
2004.
Tardive dyskinesia following brief exposure to risperidone—a case study.
European Psychiatry,
Vol. 19,
Issue. 6,
p.
391.
Margolese, Howard C
Chouinard, Guy
Kolivakis, Theodore T
Beauclair, Linda
Miller, Robert
and
Annable, Lawrence
2005.
Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 2: Incidence and Management Strategies in Patients with Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 50,
Issue. 11,
p.
703.
Tarsy, Daniel
and
Baldessarini, Ross J.
2006.
Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?.
Movement Disorders,
Vol. 21,
Issue. 5,
p.
589.
Eberhard, Jonas
Lindström, Eva
and
Levander, Sten
2006.
Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course.
International Clinical Psychopharmacology,
Vol. 21,
Issue. 1,
p.
35.
Peritogiannis, V.
and
Tsouli, S.
2010.
Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
Journal of Psychopharmacology,
Vol. 24,
Issue. 7,
p.
1121.
Tarsy, Daniel
Lungu, Codrin
and
Baldessarini, Ross J.
2011.
Hyperkinetic Movement Disorders.
Vol. 100,
Issue. ,
p.
601.
Auxéméry, Y.
2011.
Dyskinésies tardives secondaires aux neuroleptiques et antipsychotiques : quelles perspectives thérapeutiques ?.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 169,
Issue. 8,
p.
528.
Echater, S.
Oneib, B.
and
Saiz-Ruiz, Jeronimo
2023.
Improvement of Tardive Dyskinesias with Olanzapine.
Case Reports in Psychiatry,
Vol. 2023,
Issue. ,
p.
1.
Comments
No Comments have been published for this article.